Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/8/2026
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- U.S. economy adds 172,000 jobs in May, topping expectations
- Citi warns global stock markets are the frothiest since 2008
- JPMorgan upgrades Tesla, sets new price target on robotaxi and Optimus potential
- Fed risks fueling a stock bubble by overlooking AI-driven inflation: BCA
- Earthquake of magnitude 7.8 strikes off southern Philippines, tsunami warnings issued
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- Marvell Technology and Flex to join S&P 500; others to join S&P MidCap 400 and S&P SmallCap 600
- SpaceX signs $920 million monthly cloud deal with Google
- Target recalls Up & Up baby wipes due to bacterial contamination
Incyte (INCY) Misses Q1 EPS by 14c
May 3, 2022 7:11 AM EDTIncyte (NASDAQ: INCY) reported Q1 EPS of $0.55, $0.14 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $728 million versus the consensus estimate of $750.94 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
... More